C40H53N7O6S2
Neat
792.03
Room Temperature
Hydroxy Cobicistat; 1051463-40-1; R59G4A8U34; UNII-R59G4A8U34; 1, 3-thiazol-5-ylmethyl N-[(2R, 5R)-5-[[(2S)-2-[[[2-(2-hydroxypropan-2-yl)-1, 3-thiazol-4-yl]methyl-methylcarbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1, 6-diphenylhexan-2-yl]carbamate; 2, 7, 10, 12-Tetraazatridecanoic acid, 13-(2-(1-hydroxy-1-methylethyl)-4-thiazolyl)-12-methyl-9-(2-(4-morpholinyl)ethyl)-8, 11-dioxo-3, 6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R, 6R, 9S)-; SCHEMBL10200566; EBC-12156; (S)-2-((hydroxy(((2-(2-hydroxypropan-2-yl)thiazol-4-yl)methyl)(methyl)amino)methylene)amino)-N-((2R, 5R)-5-((hydroxy(thiazol-5-ylmethoxy)methylene)amino)-1, 6-diphenylhexan-2-yl)-4-morpholinobutanimidic acid; PD120383; EN300-2009860; (1, 3-thiazol-5-yl)methyl N-[(2R, 5R)-5-[(2S)-2-[({[2-(2-hydroxypropan-2-yl)-1, 3-thiazol-4-yl]methyl}(methyl)carbamoyl)amino]-4-(morpholin-4-yl)butanamido]-1, 6-diphenylhexan-2-yl]carbamate; Hydroxy Cobicistat; 2, 7, 10, 12-Tetraazatridecanoic acid, 13-[2-(1-hydroxy-1-methylethyl)-4-thiazolyl]-12-methyl-9-[2-(4-morpholinyl)ethyl]-8, 11-dioxo-3, 6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R, 6R, 9S)- (ACI); 5-Thiazolylmethyl (3R, 6R, 9S)-13-[2-(1-hydroxy-1-methylethy; Thiazol-5-ylmethyl ((2R, 5R)-5-((S)-2-(3-((2-(2-hydroxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1 and 6-diphenylhexan-2-yl)carbamate
1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[[2-(2-hydroxypropan-2-yl)-1,3-thiazol-4-yl]methyl-methylcarbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
InChI=1S/C40H53N7O6S2/c1-40(2,51)37-43-33(27-54-37)25-46(3)38(49)45-35(16-17-47-18-20-52-21-19-47)36(48)42-31(22-29-10-6-4-7-11-29)14-15-32(23-30-12-8-5-9-13-30)44-39(50)53-26-34-24-41-28-55-34/h4-13,24,27-28,31-32,35,51H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t31-,32-,35+/m1/s1